Get started
Linde plc | LIN Linde, Timeless Excellence Linde is a timeless business with even better stability than other basic materials businesses. The company works in gases and has a near-unbroken EPS growth record of 8% annually Linde is a market leader, and if you invest in the company, you're investing in the world's largest company for industrial gases. The company was originally a result of a takeover of British BOC in 2006, and again the 2018 merger of Linde and Praxair, a US company. On the macro upside, there was a 1) supportive regulatory framework in the USA and in the EU on green opportunities and hydrogen, 2) the Ukraine invasion was also a key catalyst towards the energy transition, 3) the EU chip acts with €43 billion in supporting funds as well as the United States Chips and Science Act development for a value of approximately $52 billion, and 4) higher needs of specialty gas in EV car. Related to the micro upside, the company is more diversified on a GEO revenue basis and sells different product solutions starting from cylinders to bulk liquid. In addition with a follow-up note titled "Positive News Ahead", we reported Linde's lower cost structure with the Frankfort delisting. Aside from removing the dual listing expenses, we positively view this development because US companies' P/E multiple are usually higher compared to the EU one. To support our MACRO buy case recap, in the second quarter, Linde announced two new projects with Evonik and Heidelberg Materials (both companies covered by our internal team). The company signed a long-term agreement to produce green hydrogen for Evonik in a 9-megawatt alkaline electrolyzer plant in Singapore. With Heidelberg, Linde will build a large-scale carbon capture close to the Lengfurt plant in Germany. As a reminder, cement production is estimated to be responsible for around 7% of global in 2022, APD's earnings per share were at $8.38, and Linde's earnings per share were fairly similar at $8.23. For 2023, Air Products and Chemical EPS guide a midpoint at $11.40 while Linde's EPS is forecasted at $13.65. Looking at the ROCE, in Q4 2022, APD stood at 11.7% and Linde at 13.4%. In the last quarter, APD’s ROCE was flat on the two-year comparison, while Linde’s after-tax ROCE reached 24.0%. While there are some business & regional nuances between the two leading companies (for instance, APD is lacking U.S. packaged gas business), here at the Lab, we believe are more inclined toward Linde, particularly when organic growth has been fairly similar. Cross-checking APD and Linde's last quarter results, we should recall that on a comparable basis, the German player volumes were flat with an average selling price up by 8%. On the other hand, APD increased its volume by 6% with an increase in the average selling price of 8% too. APD adj EBITDA grew by 13% while Linde achieved a plus 11%. However, Linde's EU exposure is greater than APD. Therefore, this is supportive of Linde's bottom line. In numbers, excluding the Engineering divisional performance, Linde's EMEA sales reached $2,177 million and represented 29.72% of the company's total sales. Compared to Q1 2022 number, turnover grew by 10% and was driven by a 13% of cost pass-through increase.
LLong
by moonypto
6
Palantir Bullish Long-Term PlayPalantir shares rose to a yearly high near $33 in the evening trading session on Friday, September 6, after announcement Palantir joins the S&P 500 index. Palantir was one of the strongest contenders for inclusion in the broad market S&P500 index. This inclusion, as well as Dell (DELL), comes after tech companies Super Micro (SMCI) and Crowdstrike (CRWD) also joined the index earlier this year. Technical 1-month graph indicates on Reversed Head-and-Shoulders structure in development. Potentially it can bring Palantir stocks, up to $100 per share over the next several years.
NYSE:PLTR
by Pandorra
Riding the Bullish Wave: HPQ Eyes $41.53 Long Term TargetHP Inc. (NYSE: HPQ) is showing promising signals for a short-term upside, despite recent volatility in the tech sector. According to recent reports, the stock outperformed its competitors on a strong trading day, yet faces ongoing risks to a PC market rebound, as highlighted by warnings from Citigroup. However, our Quantum Probability indicator, W.ARITAs, coupled with technical patterns, points to a solid trading opportunity. Technical Outlook: Bullish Patterns Indicate Upside Our analysis has identified two powerful overlapping bullish patterns in HPQ stock: the Bullish Harmonic Pattern - BAT and the Bullish Flag, both signaling potential upward movement. The stock has faced considerable pressure around the critical zone of $36.08, where we saw three retests, each validating the support level. Following these retests, we have now confirmed a breakout above this critical zone. The ideal entry price for investors looking to capitalize on this momentum is $36.09 . We are placing a stop loss at $34.18, protecting against potential downside, while the take-profit target is set at $41.53 , based on key resistance levels. This offers a strong risk-reward ratio of 2.89, making it a compelling short-term trade. Conclusion: High Potential Short-Term Opportunity While HPQ has faced challenges in the broader tech market, including concerns about the PC market rebound, the stock’s technical setup presents a positive outlook for short-term gains. Investors seeking to enter at $37.09 with a stop loss of $34.18 and target price of $41.53 stand to benefit from a bullish breakout and a favorable risk-reward scenario. Disclaimer: This analysis is based on technical indicators and market observations. It is not financial advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions.
NYSE:HPQLong
by insidermike
AAPL: Reacting Above a Critical Support Level (D&W Charts).Daily Chart (Left) ATH Resistance: The daily chart indicates a potential double top pattern near the all-time high (ATH) at around $237.23, signaling a possible resistance zone that could lead to a bearish reversal if not breached in the next few weeks. Mid-Term Support: The $221.33 level is acting as a mid-term support. A break below this level could imply further downside potential reversing the long-term trend, while a hold above could suggest consolidation or a reversal attempt to retest the ATH again. Weekly Chart (Right) Sideways Movement with Weekly EMA Support: The weekly chart shows a range-bound movement with $237.23 acting as a key resistance. The 21-week EMA is supporting the price, suggesting that buyers may still have interest at current levels. This EMA ccoicindes with the $221 support observed on the daily chart, reinforcing its importance. Consolidation Phase: The stock is in a consolidation phase just below its ATH, which could be indicative of a buildup before a breakout. Trading Implications: AAPL's chart shows signs of potential reversal to the ATH, as it remains supported by mid-term and weekly EMA support levels, and we see a bullish reaction in this area. However, if it loses the $221, along with the 21-week EMA, i'll reject the bullish thesis. For more detailed technical analyses and insights like this, be sure to follow my account. Your support helps me continue providing valuable content to help you make informed trading decisions. Remember, real trading is reactive, not predictive, so let's stay focused on the key points described above and only trade when there is confirmation. “To anticipate the market is to gamble. To be patient and react only when the market gives the signal is to speculate.” — Jesse Lauriston Livermore All the best, Nathan.
NASDAQ:AAPL
by Nathan_The_Finance_Hydra
11/5/24 - $uber - What's not to like, buying <$75 11/5/24 :: VROCKSTAR :: NYSE:UBER What's not to like, buying <$75 - cash heavy portfolio looking for some high quality "into-year-end" plays where i can leverage the book with calls in order to keep a. cash heavy for real dips and b. where i think there will be a lot to do, so i want to remain nimble - NYSE:UBER seems to check a lot of boxes. sales growth mid teens with fairly high visibility, "check". platform that doesn't have much competition "check". expanding margins "check". valuation reasonable at low 20s PE (so PEG is ~1.2-1.3x ish) "check". just beat earnings "check". - name seems to have a perma-bid for good reasons. i'm getting busy with the jan 17 2025 65C's which offer me some healthy 6x leverage. - plan is monetize 1/3 of the stake if DJT results in a further squeeze tmr... figure out what to do with the rest. but i think we'll be at 100 by next year. so i'm genuinely eyeing the jan 2027s and ironically hoping for a dip where i can get busy with bigger size and longer duration. what do u think? V
NYSE:UBERLong
by VROCKSTAR
VZ in the buy areaHi Traders Verizon Communications Inc (VZ) is in an uptrend since October ’23. The price level broke the resistance and seems to confirm the fact that the old resistance level serves as a support level right now. I suspect the stock to make a new higher high as long as the uptrend doesn’t get invalidated. In other words, if the stock price doesn’t fall below it’s support range between $38.8 and $41. We can, thus, see this range as the buy area. Also in terms of fundamental analysis, there is something to say about this stock. VZ is a company that benefits a lot from the current TCJA law in the US. A law that was signed in 2017 and that reduces the average effective tax rate for large corporations. It’s a law that has been critized for disproportionately benefiting higher-income corporations, like VZ. Many key elements of the TCJA are set te expire in 2025 and whether these elements will be extended depends on who will become US’s new president. Trump wants to extend the TCJA elements that are so beneficial for higher-income corporations. Harris, on the other hand, doesn’t want this. Therefore, VZ’s future profits are expected to be higher if Trump wins the election because, in that case, they will be able to benefit more from the current tax benefits. To conclude, I would wait for the election results to decide whether to enter the trade. If Trump wins, I forecast that the stock’s trend will be even bullisher. In that case, I would enter the trade in the buy area, target a price level of $47.6 and put a stop-loss at $37.8.
NYSE:VZLong
by vf_investment
PLTR: Explosive Move! New ATH After Earnings Report.Daily Chart (Left) Explosive Move: The price surged more than 20% following a strong earnings release, indicating high investor interest and strong buying momentum. New Support at $45: The $45 level, previously acting as resistance, now serves as a potential support according to the principle of polarity. Monitoring this level is crucial for any pullbacks or consolidations. Therefore, even if we see PLTR losing momentum, any pullback to the $45 won't ruin the uptrend. Strong Uptrend: The moving average (21 EMA) supports the ongoing bullish trend, with the price well above it. Weekly Chart (Right) All-Time High Breakout: The price has broken past its previous all-time high, confirming strong bullish momentum on a larger time frame. Sustained Upward Trend: The consistent uptrend since mid-2023 continues with increasing strength, supported by a steep rise in the weekly 21 EMA. Trading Implications: PLTR is currently experiencing strong bullish momentum, marked by an impressive breakout following earnings. The $45 level is crucial to watch for potential support on pullbacks. The trend remains bullish as long as the price stays above the 21 EMA and the support level holds. For more detailed technical analyses and insights like this, be sure to follow my account. Your support helps me continue providing valuable content to help you make informed trading decisions. Remember, real trading is reactive, not predictive, so let's stay focused on the key points described above and only trade when there is confirmation. “To anticipate the market is to gamble. To be patient and react only when the market gives the signal is to speculate.” — Jesse Lauriston Livermore All the best, Nathan.
NYSE:PLTR
by Nathan_The_Finance_Hydra
Strong Buy!Im a buyer of this stock..Im long Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that a late-breaking abstract including new long-term extension (LTE) data from the Phase 2 trial of tamuzimod in ulcerative colitis was presented on October 15, 2024 during the United European Gastroenterology (UEG) Week meeting in Vienna, Austria. We are excited to present the new long-term extension data from the tamuzimod Phase 2 trial in patients with ulcerative colitis at UEG Week,” said Raju Mohan, PhD, Chief Executive Officer. “These 52-week data continue to reinforce the potential best-in-class profile of our S1P1R modulator tamuzimod in ulcerative colitis, with a potential best-in-disease safety profile amongst all the oral options for UC therapy. We believe the high rates of clinical remission and endoscopic remission position tamuzimod as the backbone of future combination therapies for UC.”
NASDAQ:VTYXLong
by sebastiannatalia
META: A Dangerous Inflection Point! (D&H Chart Analysis).Daily Chart (Left) Ascending Channel: The price has been trending within an ascending channel, indicating a strong upward trend that has held for a considerable period. Double Support Area: There is a critical support zone at $561.52, marked by both horizontal support and the lower trend line of the ascending channel. This convergence of support points suggests that this level is pivotal for maintaining the current trend. Price Reaction: Recently, the price tested the support area and rebounded, but it is still below the 21-day EMA. Hourly Chart (Right) 21-Hour EMA Resistance: The price recently encountered resistance at the 21-hour EMA as well, which may act as a short-term barrier for further upward movement. Pullback Zone: The recent dip tested the support area around $561.52, validating it as a strong inflection point. The price is now attempting a recovery from this support level. Conclusion: The $561.52 level is crucial for both bullish and bearish traders. If the price maintains above this zone, there could be potential for a rebound and continuation within the ascending channel. Conversely, failure to hold this support could lead to a bearish reversal or deeper correction. Keeping an eye on the reaction to the 21-hour EMA will provide clues for short-term movement. For more detailed technical analyses and insights like this, be sure to follow my account. Your support helps me continue providing valuable content to help you make informed trading decisions. Remember, real trading is reactive, not predictive, so let's stay focused on the key points described above and only trade when there is confirmation. “To anticipate the market is to gamble. To be patient and react only when the market gives the signal is to speculate.” — Jesse Lauriston Livermore All the best, Nathan.
NASDAQ:META
by Nathan_The_Finance_Hydra